BTL Medical Technology

What BTL Medical Technology does

BTL Medical Technology (legal entity: BTL Medizintechnik GmbH, headquartered in Dornstadt, Germany; group founded in Prague in 1993) is a privately held, family-owned manufacturer of non-invasive medical and aesthetic devices. The company sells three principal product families: (i) rehabilitation and orthopaedics equipment — including radial and focused shockwave therapy, high-intensity laser, electrotherapy with 30+ waveforms, ultrasound, spinal decompression, cryotherapy, and the BTL Robotics suite (BTL Exo, R-Gait, R-FORCE anti-gravity treadmill, R-Touch, R-Lead, BTL Walk); (ii) cardiology and pulmonology systems — including BTL 8 ECG, BTL 4 ECG, BTL Flexi ECG, stress test, Holter ECG, ABPM, spirometry, CPET, and the BTL CardioPoint all-in-one diagnostic software with AI-powered interpretation; and (iii) aesthetic medicine devices, notably EMSELLA and Exomind, plus a veterinary division launched in 2023. Proprietary technology differentiators include AI-powered ECG interpretation trained on tens of thousands of patient recordings, hands-free rotational-field ultrasound, dual-coil Super Inductive System, anti-gravity treadmill mechanics, and lipid nanoparticle R&D via an investment in Adalid Sciences. The company employs more than 4,000 people globally (some sources cite 4,500+), including approximately 600 R&D engineers, and operates company-owned manufacturing in Benešov, Czech Republic and Plovdiv, Bulgaria.

BTL generates revenue primarily through direct hardware sales of medical devices, supplemented by service contracts, technical inspections (STK), and training. Distribution is exclusively enterprise B2B via BTL's own direct sales subsidiaries on 5 continents across more than 80 countries, supplemented by trading partners in selected regions; the company does not sell directly to consumers, although a Provider Locator tool on its website drives patient referrals to clinics equipped with BTL products. Standard commercial terms apply only to businesses (clinics, hospitals, physiotherapists) under §310 BGB, with payment terms of 14 days net from invoice date and no publicly disclosed list pricing. Customer segments span rehabilitation and orthopaedic clinics, cardiology and pulmonology departments, aesthetic clinics, and veterinary practices, supported by approximately 1,000 annual continuing education events and a multi-channel marketing program combining trade shows (e.g., therapie Hamburg, therapro Stuttgart), clinical publications, the BTL Education platform, and social channels. With more than 500,000 installed systems worldwide and 70,000+ users across 80+ countries, BTL positions itself as a market leader in the non-invasive therapy segment of medicine.

Name

BTL Medical Technology

Legal name

BTL Medizintechnik GmbH

Website

https://btlmed.de

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

11–50 employees

Short description

BTL Medical Technology is a privately held, family-owned German-Czech manufacturer of non-invasive medical and aesthetic devices, serving hospitals, clinics, and physiotherapists worldwide with rehabilitation, cardiology, and robotics hardware across 80+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Dornstadt

HQ country

Germany

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Hardware Sales: BTL generates revenue primarily through the sale of medical devices including rehabilitation equipment (shockwave therapy, electrotherapy, ultrasound, high-intensity laser, spinal decompression, robotics), cardiology systems (ECG, stress test, Holter, ABPM, spirometry, CPET), and aesthetic medicine devices. Products are sold directly through BTL's own sales companies in over 80 countries, supplemented by distribution partners.
2. Service and Technical Support: BTL provides worldwide technical support through factory-trained service technicians present at most branches and distribution partners. Service offerings include maintenance, repair, safety technical inspections (STK), and technical training for customers.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels10 records

Core offering

BTL Medical Technology designs, manufactures, and globally distributes medical devices for rehabilitation (shockwave, laser, electrotherapy, ultrasound, high-intensity laser, spinal decompression, robotic neurorehabilitation), cardiology (AI-powered ECG, stress testing, Holter monitoring, ABPM, spirometry, CPET, CardioPoint software), and aesthetic medicine (EMSELLA, Exomind). The company owns manufacturing in Europe (Czech Republic, Bulgaria) and sells through direct sales subsidiaries in 80+ countries, targeting clinics, hospitals, and physiotherapy practices.

Differentiator

Problem solved

Functional benefit

Brands

• BTL Robotics: Robotic systems for rehabilitation including Exo, R-Gait, R-Force, R-Touch, R-Lead, and BTL Walk
• BTL Aesthetics
• BTL CardioPoint
• BTL Physiotherapie

Products and services

• BTL Robotics (BTL Exo, R-Gait, R-Force, R-Touch, R-Lead, BTL Walk) Task-specific neurorehabilitation robots providing high-repetition training with individually graded intensity across all phases of neurorehabilitative care. R-FORCE uses an airtight pressure chamber to reduce patient body weight by up to 100% for realistic pain-free gait, with real-time feedback, integrated wide-angle camera, and game-based therapy elements.
• Super Inductive System DUO (SIS DUO) High-intensity electromagnetic therapy system with two independent channels enabling simultaneous treatment of different body areas or two patients. Features a 3D applicator with dual-coil technology for high-intensity stimulation of joints and large muscle groups to reduce pain, improve mobility, and accelerate functional rehabilitation.
• Radial Shockwave Therapy Device

Quantifiable outcome

• 19% better improvement in Neck Disability Index and 24% higher pain reduction with spinal decompression therapy compared to conventional rehabilitation alone
• +4 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature12 records

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Cynosure: Established aesthetic medical device manufacturer with overlapping energy-based and body-contouring systems; competes with BTL Aesthetics in dermatology and medical-spa channels.
• Zimmer Biomet: Global orthopedic medical device incumbent with adjacent rehabilitation/physiotherapy footprint; competes with BTL indirectly in orthopedic hospitals and adjacent rehab settings.
• Stryker: Diversified multi-billion-dollar medical device company whose MedSurg segment (including rehabilitation capital equipment) competes with BTL for hospital capital budgets and large IDN contracts.
• OMRON Healthcare: Global leader in personal cardiology/ECG and blood-pressure monitoring devices; competes with BTL's Flexi ECG, ABPM, and Holter products at the consumer/clinical cardiology boundary.
• GE HealthCare: Global incumbent in cardiology diagnostics (ECG, stress, Holter, ABPM) and broader patient monitoring; competes with BTL Cardiology at the hospital and IDN level where multimodal platform purchases dominate.

Direct peers

• Inmode: Israeli aesthetic medical device company offering non-invasive body-contouring, skin, and wellness platforms that overlap with BTL Aesthetics (EMSELLA, Exomind) in the same medical-spa and OB/GYN channels.
• DJO Global (Enovis): Enovis (formerly Colfax/DJO) is one of the largest global orthopedic and rehabilitation medical device companies, with overlapping franchises in physical therapy equipment, bracing, and pain management — directly competing with BTL's rehabilitation line.
• Storz Medical: Swiss-headquartered manufacturer of shockwave therapy systems (radial and focused), a direct head-to-head competitor in BTL's core radial/focused shockwave therapy franchise.
• Elvation Medical: European-based medical device company distributing shockwave, focused, and aesthetic devices; competes with BTL in rehabilitation and aesthetic medicine channels across DACH and broader EMEA.
• Schiller AG: Swiss competitor with a directly overlapping cardiology product line (resting ECG, stress test, Holter, ABPM, spirometry, cardiopulmonary diagnostics) targeted at the same hospitals and cardiology practices as BTL's CardioPoint platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@BTLmedicalinternational
• Facebookfacebook.com/BTLMedicalDeutschland
• LinkedInlinkedin.com/company/btl-medizintechnik-gmbh
• Instagraminstagram.com/btlmedizintechnik

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BTL Medical Technology